Skip to main content

Table 1 Characteristic of patients undergoing HoLEP

From: Preoperative predictors of enucleation time during en bloc ‘no-touch’ holmium laser enucleation of the prostate

Characteristic

Data

Total patients, n

135

Age (year), mean (SD)

71.7 (9.3)

History of 5ARi use, n (%)

21 (16)

Requiring Foley catheter at the time of HoLEP, n (%)

14 (10.3)

History of UTI, n (%)

12 (9)

History of anticoagulation, n (%)

13 (10)

Pre-HoLEP PSA (ng/mL), mean (range)

6.2 (0.07–1380)

Previous TURP, n (%)

12 (9)

TRUS-P volume (g), mean (SD)

71.1 (42.8)

 < 50 ml, n (%)

51 (37.7)

 50–80 ml, n (%)

51 (37.7)

 > 80 ml, n (%)

33 (24.4)

  1. 5ARi 5-alpha-reductase inhibitor, HoLEP holmium laser enucleation of the prostate, PSA prostate-specific antigen, SD standard deviation, TRUS-P transrectal ultrasound of the prostate, UTI urinary tract infection